Differentiating infected from vaccinated animals: Validation and application of NH-AGID assay in heifers immunized with Brucella abortus strain A19-∆VirB12

区分感染动物与接种疫苗动物:NH-AGID 检测方法在接种布鲁氏菌 A19-∆VirB12 株的母牛中的验证和应用

阅读:1

Abstract

Differentiating infected from vaccinated animals is crucial for clinical diagnosis in brucellosis control. The objective of this study was to assess the performance of native hapten agar gel immuno-diffusion(NH-AGID) in differential identification of infected heifers from vaccined with strain A19-∆VirB12 and identifying shedding animals at the serologic level. 30 heifers were vaccined with A19-∆VirB12, and corresponding serum and vaginal swab samples were collected at predetermined intervals. Serological assessments were conducted using the Rose-bengal test, serum agglutination test, competitive enzyme-linked immunosorbent assay and NH-AGID. Brucella-positive sera were further distinguished using differential identification ELISA and NH-AGID. Vaginal swab DNA was tested using AMOS-PCR and dual real-time fluorescence PCR. Results showed that NH-AGID demonstrated a high specificity and positive predictive values (PPV) for diagnosis of brucellosis. Additionally, the diagnostic accuracy of NH-AGID for infected and shedding animals was more than 90 %. Heifers vaccinated with A19-∆VirB12 were serologically confirmed as infected by NH-AGID and also tested positive by PCR. The application of NH-AGID effectively identified infected and shedding animals from vaccination with A19-∆VirB12, thereby supporting the brucellosis decontamination efforts.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。